FROM U.S. Regional Biocontainment Laboratories (RBL) after testing of Brilacidin... the data supported Brilacidin's DIRECT INHIBITION of SARS-Co V-2, the novel coronavirus responsible for COVID-19..,
... here is a Quote form one of the U of Penn scientist/designers of Brilacidin, which has been referred to as a "miracle drug", with my caps included: . “We've designed oligomer and small molecule compounds that do indeed replicate the function of defensins. They're potent and broad spectrum. We've tested them against more than 25 different bacterial strains, including strains of bacteria that are resistant to antibiotics, and they work against all of them. They also have antifungal and ANTIVIRAL properties and are very INEXPENSIVE and VERY EASY to make”